Search Results

Filter
  • 1-10 of  359 results for ""Drug Eruptions""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Baccharis dracunculifolia (Asteraceae) essential oil displays anti-inflammatory activity in models of skin inflammation.

  • Authors : Brandenburg MM; Department of Pharmacology, Universidade Federal do Paraná, Curitiba, PR, Brazil. Electronic address: .; Rocha FG

Subjects: Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*pharmacology ; Baccharis/Baccharis/Baccharis/*chemistry ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*drug therapy

  • Source: Journal of ethnopharmacology [J Ethnopharmacol] 2020 Sep 15; Vol. 259, pp. 112840. Date of Electronic Publication: 2020 Apr 05.Publisher: Elsevier Sequoia Country of Publication: Ireland NLM ID: 7903310 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Treatment of PD-1/PD-L1 Inhibitor-Induced Dermatitis Resolves Concomitant Eruptive Keratoacanthomas.

  • Authors : Crow LD; Department of Dermatology, University of California, San Francisco.; Perkins I

Subjects: Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*administration & dosage ; Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/*adverse effects ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*etiology

  • Source: JAMA dermatology [JAMA Dermatol] 2020 May 01; Vol. 156 (5), pp. 598-600.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Paradoxical psoriasis induced by TNF-α blockade shows immunological features typical of the early phase of psoriasis development.

  • Authors : Fania L; Laboratory of Experimental Immunology and 1st Dermatology Division, IDI-IRCCS, Rome, Italy.; Morelli M

Subjects: Adalimumab/Adalimumab/Adalimumab/*adverse effects ; Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*adverse effects ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*immunology

  • Source: The journal of pathology. Clinical research [J Pathol Clin Res] 2020 Jan; Vol. 6 (1), pp. 55-68. Date of Electronic Publication: 2019 Oct 29.Publisher: Wiley Blackwell Country of Publication: England NLM ID: 101658534 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

[Triggers of exanthematous drug eruptions: Stop intake, treat through or desensitization?]

  • Authors : Absmaier M; Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein, Technische Universität München, Biedersteiner Str. 29, 80802, München, Deutschland.; Biedermann T

Subjects: Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*therapeutic use ; Desensitization, Immunologic/Desensitization, Immunologic/Desensitization, Immunologic/*methods ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*prevention & control

  • Source: Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete [Hautarzt] 2017 Jan; Vol. 68 (1), pp. 29-35.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0372755 Publication Model: Print Cited Medium: Internet ISSN: 1432-1173

Record details

×
Academic Journal

Incidence of cutaneous reactions with pemetrexed: Comparison of patients who received three days of oral dexamethasone twice daily to patients who did not.

  • Authors : Clark SK; Department of Pharmacy, University of New Mexico Hospitals, Albuquerque, NM, USA.; Anselmo LM

Subjects: Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*administration & dosage ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*adverse effects ; Dexamethasone/Dexamethasone/Dexamethasone/*administration & dosage

  • Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2019 Oct; Vol. 25 (7), pp. 1645-1650. Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Anti-Tumor Necrosis Factor-α-Induced Dermatological Complications in a Large Cohort of Inflammatory Bowel Disease Patients.

  • Authors : Andrade P; Gastroenterology Department, Centro Hospitalar São João, University of Porto Medical School, Alameda Prof. Hernani Monteiro, 4200-319, Porto, Portugal. .; Lopes S

Subjects: Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*adverse effects ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*epidemiology ; Gastrointestinal Agents/Gastrointestinal Agents/Gastrointestinal Agents/*adverse effects

  • Source: Digestive diseases and sciences [Dig Dis Sci] 2018 Mar; Vol. 63 (3), pp. 746-754. Date of Electronic Publication: 2018 Jan 18.Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 7902782 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Comparison of the Effects of Mitochondria-Targeted Antioxidant 10-(6'-Plastoquinonyl)Decyltriphenylphosphonium Bromide (SkQ1) and a Fragment of its Molecule Dodecyltriphenylphosphonium on Carrageenan-Induced Acute Inflammation in Mouse Model of Subcuteneous Air Pouch.

Subjects: Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*pharmacology ; Antioxidants/Antioxidants/Antioxidants/*pharmacology ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*prevention & control

  • Source: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2017 Apr; Vol. 162 (6), pp. 730-733. Date of Electronic Publication: 2017 Apr 21.Publisher: Springer Country of Publication: United States NLM ID: 0372557 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Disease-related and drug-induced skin manifestations in inflammatory bowel disease.

  • Authors : Hindryckx P; a Department of Gastroenterology , University of Ghent , Ghent , Belgium.; Novak G

Subjects: Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*adverse effects ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*epidemiology ; Erythema Nodosum/Erythema Nodosum/Erythema Nodosum/*epidemiology

  • Source: Expert review of gastroenterology & hepatology [Expert Rev Gastroenterol Hepatol] 2017 Mar; Vol. 11 (3), pp. 203-214. Date of Electronic Publication: 2017 Feb 01.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278199 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Linear localized morphea associated with golimumab in a patient with spondyloarthritis.

  • Authors : Torrente-Segarra V; Servicio de Reumatología, Hospital Comarcal Alt Penedès, Vilafranca del Penedès, Barcelona, España. Electronic address: .; Campo P

Subjects: Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*adverse effects ; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*adverse effects ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*etiology

  • Source: Reumatologia clinica [Reumatol Clin (Engl Ed)] 2020 Jul - Aug; Vol. 16 (4), pp. 303-305. Date of Electronic Publication: 2018 Aug 14.Publisher: Elsevier Doyma Country of Publication: Spain NLM ID: 101717526 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Pattern and Severity of Psoriasiform Eruptions in Patients with Inflammatory Bowel Diseases, Arthritis or Skin Inflammatory Disorders Treated with TNF-alpha Inhibitors.

  • Authors : Darrigade AS; Department of Dermatology and Pediatric Dermatology, National Centre for Rare Skin Disorders, Saint-André Hospital, Bordeaux, France.; Milpied B

Subjects: Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*adverse effects ; Arthritis/Arthritis/Arthritis/*drug therapy ; Dermatitis/Dermatitis/Dermatitis/*drug therapy

  • Source: Acta dermato-venereologica [Acta Derm Venereol] 2017 Jun 09; Vol. 97 (6), pp. 731-734.Publisher: Society for the Publication of Acta Dermato-Venereologica Country of Publication: Sweden NLM ID: 0370310 Publication Model: Print Cited Medium:

Record details

×
  • 1-10 of  359 results for ""Drug Eruptions""